KEN TAKANASHI - 12 Aug 2024 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role: Director, 10%+ Owner
Signature: /s/ Ken Takanashi
Issuer symbol: WVE
Transactions as of: 12 Aug 2024
Net transactions value: $0
Form type: 4
Filing time: 14 Aug 2024, 18:00:03 UTC
Previous filing: 09 Aug 2023
Next filing: 07 Aug 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WVE	Ordinary Shares	Award	$0	+16,115	+0.28%	$0.000000	5,721,175	12 Aug 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WVE	Share Option (right to buy)	Award	$0	+32,230		$0.000000	32,230	12 Aug 2024	Ordinary Shares	32,230	$5.37	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person was granted this restricted share unit award (RSU) pursuant to the 2024 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025.
F2	The reporting person was granted this option pursuant to the 2024 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025.